Company Developments - The company announced the completion of the acquisition of ophthalmic equipment manufacturer LKC Technologies on February 3, 2026, which has been integrated into the Electronic Instruments Group (EIG) to expand its ophthalmic product portfolio. This strategic move aims to enhance the company's market position in the medical device sector, with future integration progress and business synergy effects becoming focal points [1]. Financial Outlook - According to the company's outlook released in February 2026, it expects a year-over-year sales growth of approximately 10% for the first quarter, with adjusted earnings per share projected to be between $1.85 and $1.90 (a year-over-year increase of 6% to 9%). For the full year, sales are anticipated to achieve mid-single-digit growth, with adjusted diluted earnings per share guidance set at $7.87 to $8.07 (an increase of 6% to 9% compared to 2025). The actual performance will be compared against this outlook, reflecting the execution efficiency of the company's growth strategy [2]. Institutional Perspectives - Recently, several institutions updated their ratings, with Mizuho Securities raising its target price to $235 on February 5, 2026, and DBS Bank increasing it to $265. The current average target price among institutions is $250.81, with 59% recommending buy or hold, indicating a positive market outlook regarding the acquisition and performance prospects. Changes in institutional perspectives may influence short-term stock price volatility [3].

Core Viewpoint - The article emphasizes the establishment of a communication platform by Suyu MedTech that connects innovators, clinicians, business managers, investors, and researchers to facilitate resource sharing and project advancement, aiming for a systematic and sustainable approach by 2026 [2]. Group 1: Conference System - The conference system will focus on "medical-engineering intersection, real-world innovation, clinical value, and industry frontiers," aiming to build a top-level communication framework within the industry [3]. - The planned conferences for 2026 include: - March 19, 2026: Third Medical Device R&D Forum in Beijing - April 24, 2026: Fourth Medical Device R&D Forum in Beijing (tentative) - May 28, 2026: Second Global Aesthetic Technology Conference in Shenzhen (tentative) - June 11, 2026: Second Global Ophthalmology Conference in Beijing - July 9, 2026: Third Global Biopharmaceutical Conference in Beijing [4][5]. Group 2: Weekly Closed-Door Activities - Starting in 2026, a weekly closed-door activity system will be established to facilitate more focused and practical exchanges [7]. - Expected themes for these activities include: 1. Global enterprise landscape and industry chain observation 2. Technological innovation in clinical scenarios 3. Market access, pricing, and insurance 4. Branding and communication strategies [8]. Group 3: Lab to Market Training Series - A systematic training course will be developed for engineers, researchers, clinicians, and entrepreneurs, focusing on the transition from lab to market [10]. - The article invites feedback from industry professionals regarding their roles, product lines of interest, industry pain points, and desired event types to tailor the activities effectively [10][12].

文章来源：眼未来 转载要求：首发24小时后可转载，需注明来源 思宇年度活动回顾： 首届全球眼科大会 | 首届全球骨科大会 | 首届全球心血管大会 即将召开： 2025年7月17日，第二届全球医疗科技大会 P.S. 中标周报会每周定期更新 。 P.P.S. 由于民营医院、军队、某些特殊采购，不走招投标，还有一些打包的采购，数量不易统计，因此 眼科 设备 的真实销售数量，比能查出来的多 ——眼未来希望能给到业内完整的数据，避免误导投资人。因此， 欢 迎 厂商主动反馈真实数据——更透明、更有利于行业发展 。 欢迎企业积极参与思宇组织的大会↓ 2025年7月17日，第二届全球医疗科技大会 2025年9月4-5日，第三届全球手术机器人大会 中国地区眼科设备中标周报（2025.06.06-2025.06.12） 过去 7 日共有 13 个不同的采购单位，包括医院和社区服务中心。 1. 采购标的 ：共有 12 种 不同的眼科设备，涵盖了从基础检查设备到高级治疗设备。 2. 品牌 ：涉及多个品牌，包括蔡司、爱尔康、新眼光医疗、天津迈达等。 3. 数量 ：总共采购了 超 29 套 设备（含12套设备系统升级），单次采购数量基本 ...

1. 采购标的 ：共有 12 种 不同的眼科设备，涵盖了从基础检查设备到高级治疗设备。 文章来源：眼未来 转载要求：首发24小时后可转载，需注明来源 思宇年度活动回顾： 首届全球眼科大会 | 首届全球骨科大会 | 首届全球心血管大会 即将召开： 2025年7月17日，第二届全球医疗科技大会 2025年9月4-5日，第三届全球手术机器人大会 中国地区眼科设备中标周报（2025.06.06-2025.06.12） 过去 7 日共有 13 个不同的采购单位，包括医院和社区服务中心。 2. 品牌 ：涉及多个品牌，包括蔡司、爱尔康、新眼光医疗、天津迈达等。 3. 数量 ：总共采购了 超 29 套 设备（含12套设备系统升级），单次采购数量基本均为一套。 4. 中标金额 ：总中标金额达到 1547.63 万元 ，其中单个设备最高中标金额为 252.7 万元 。 P.S. 中标周报会每周定期更新 。 P.P.S. 由于民营医院、军队、某些特殊采购，不走招投标，还有一些打包的采购，数量不易统计，因此 眼科 设备 的真实销售数量，比能查出来的多 ——眼未来希望能给到业内完整的数据，避免误导投资人。因此， 欢 迎 厂商主动反馈真 ...